Navigation Links
Albemarle to increase ibuprofen prices
Date:5/25/2012

BATON ROUGE, La., May 25, 2012 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global developer, manufacturer and marketer of highly engineered specialty chemicals, announced today that it will increase global prices for all grades of ibuprofen by an estimated 15% effective immediately, or as contracts allow. 

(Logo: http://photos.prnewswire.com/prnh/20111129/MM14279LOGO )

Albemarle's ibuprofen and other generic active pharmaceutical ingredients (APIs) are part of the company's Fine Chemistry Services division in the Fine Chemistry global business unit.  Albemarle's Fine Chemistry Services division manufactures and markets bulk and niche active pharmaceutical ingredients for over-the-counter and prescription drugs, and provides custom manufacturing, R&D and other services to makers of pharmaceuticals, agricultural chemicals, specialty materials and other high-value markets.

About Albemarle
Albemarle Corporation, headquartered in Baton Rouge, Louisiana, is a leading global developer, manufacturer, and marketer of highly-engineered specialty chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, automotive/transportation, pharmaceuticals, crop protection, food-safety and custom chemistry services. Albemarle is committed to global sustainability and is advancing its eco-practices and solutions in its three business segments, Polymer Solutions, Catalysts and Fine Chemistry. Corporate Responsibility Magazine selected Albemarle to its prestigious "100 Best Corporate Citizens" list for 2010 and 2011.  Albemarle employs approximately 4,000 people and serves customers in approximately 100 countries. Albemarle regularly posts information to www.albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, Regulation G reconciliations, SEC filings, and other information regarding the Company, its businesses and the markets we serve.

Albemarle's Fine Chemistry Services (FCS) division is an innovative, full-service provider of fine chemicals to the world's leading companies across the pharmaceutical, agrichemical, and specialty materials markets.  Albemarle's FCS division helps global customers complete hundreds of successful projects through a powerful combination of proven chemistry expertise, game-changing process development, high-quality custom manufacturing and exceptional service.  From innovative R&D to commercial-scale production, Albemarle's FCS division delivers the knowledge, experience, resources, creativity and service you need to move products to market faster and accelerate your business.  To learn more about Albemarle's FCS division, please visit www.albemarle.com/fcs.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding Albemarle Corporation's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report on Form 10-K.


'/>"/>
SOURCE Albemarle Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Joseph M. Mahady Joins Albemarle Board of Directors
2. Albemarle(R) Announces Custom Manufacturing Alliance with PharmaCore(R)
3. Albemarle Optimizes Smallpox Drug Candidate for SIGA
4. Physician-Friendly Coding and Compliance Tool Increases Accuracy and Documentation of Patient Charges
5. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
6. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
7. Hypertension Drug Adherence Associated with Fewer Hospitalizations and Lower Medical Costs but Increased Total Care Costs
8. Make What You Say Matter and Increase Your Chances of Being Heard With Communication Experts Latest E-book, "Can You Hear Me Now?"
9. Pharmatek Increases Liquid Filled Capsule Capacity
10. Medbox, Inc. Supports Increased Regulation on the California Medical Marijuana Industry
11. Entering its Prime: Southeast Michigan ePrescribing Initiative, One of the Nations Longest Running ePrescribing Programs, Increases Enrollment by 33 Percent; Kicks off Seventh Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global ... and Gynecology markets with innovative and proprietary products, will ... 31, 2017 after the market close on Tuesday, May ... a conference call and webcast to discuss its financial ... at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ...
(Date:4/18/2017)...  Astute Medical, Inc., developer of biomarkers for better ... at the 2017 National Kidney Foundation (NKF) Spring ... April 22. Physicians will present data on two biomarkers, ... for acute kidney injury (AKI) during the management of ... Elevated levels of TIMP-2 and IGFBP-7 have been ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... MAP Health Management ... levels in people with addiction who are served by MAP’s patient engagement ecosystem. ... device that monitors heart and breath rates to identify anxiety levels and can ...
(Date:4/24/2017)... ... ... Come to PAINWeekEnd (PWE) Tampa on May 20 and 21, at the ... 2-day program. , An attendee at a recent PAINWeekEnd said, "Very helpful, wish ... course entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant Behavior, presented by Dr. ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Reflections of God’s Work”: an ... of God’s Work” is the creation of published author, Jerri Broglin, a survivor of ... , “I believe this a great eye-opener for those searching for answers, as we ...
(Date:4/24/2017)... ... ... Life of Purpose Treatment is proud to present “An Evening for Collegiate Recovery ... on May 10th at the University Auditorium. , This benefit concert, featuring Dr. Cheryl ... Collegiate Recovery Community (UFCRC). The concert will kick off the 5th Annual Southeastern CRC ...
(Date:4/23/2017)... ... April 23, 2017 , ... "An event Horizon is a place where the ... my Art and Music. These are created as Metaphysical Transformations where music, which is ... culminate to the ultimate singularity.", -- Karen Salicath Jamali , Karen will also preview ...
Breaking Medicine News(10 mins):